Volitionrx (VNRX) Equity Average (2019 - 2025)
Volitionrx's Equity Average history spans 9 years, with the latest figure at -$35.1 million for Q4 2025.
- For Q4 2025, Equity Average fell 44.06% year-over-year to -$35.1 million; the TTM value through Dec 2025 reached -$35.1 million, down 44.06%, while the annual FY2025 figure was -$30.9 million, 77.2% down from the prior year.
- Equity Average reached -$35.1 million in Q4 2025 per VNRX's latest filing, down from -$33.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $28.9 million in Q2 2021 to a low of -$35.1 million in Q4 2025.
- Average Equity Average over 5 years is -$4.6 million, with a median of -$1.6 million recorded in 2022.
- Peak YoY movement for Equity Average: skyrocketed 107.52% in 2021, then plummeted 3927.22% in 2023.
- A 5-year view of Equity Average shows it stood at $19.5 million in 2021, then crashed by 100.74% to -$143567.0 in 2022, then tumbled by 3927.22% to -$5.8 million in 2023, then plummeted by 321.57% to -$24.4 million in 2024, then tumbled by 44.06% to -$35.1 million in 2025.
- Per Business Quant, the three most recent readings for VNRX's Equity Average are -$35.1 million (Q4 2025), -$33.9 million (Q3 2025), and -$31.1 million (Q2 2025).